Pharmacological management of chronic idiopathic constipation
Overview
Chronic idiopathic constipation (CIC) is defined as a common disorder associated with significant impairment in quality of life. The clinical practice guideline, jointly developed by the American Gastroenterological Association and the American College of Gastroenterology, aims to inform clinicians and patients by providing evidence-based practice recommendations for the pharmacological treatment of CIC in adults.
Learning objectives
- Providing clinicians and patients with evidence-based practice recommendations for the pharmacological treatment of CIC in adults.
- Answering questions from the gastroenterology community about the newly published recommendations.
Key dates
- Released date:
- Aug 15, 2023
- Expiration date:
- Aug 09, 2026
Pricing
Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Video
45 mins
Evaluation
Course Faculty
Faculty
William D. Chey, MD, AGAF
RFF Division of Gastroenterology & Hepatology, Michigan Medicine, Ann Arbor, Michigan
Anthony J. Lembo, MD
Department of Gastroenterology, Hepatology & Nutrition, Digestive Disease and Surgery Institute; Cleveland Clinic, Cleveland, Ohio
Shahnaz Sultan, MD, MHSc, AGAF
Minneapolis VA Healthcare System, Minneapolis, Minnesota University of Minnesota
Lin Chang, MD, AGAF
Vatche and Tamar Manoukian Division of Digestive Diseases David Geffen School of Medicine at UCLA